HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zsolt Cselényi Selected Research

fenobam

1/2020The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zsolt Cselényi Research Topics

Disease

7Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2009
4Parkinson Disease (Parkinson's Disease)
01/2021 - 09/2015
3Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2003 - 08/2002
2Neoplasms (Cancer)
12/2021 - 01/2020
2Neuroinflammatory Diseases
09/2015 - 06/2011
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2015 - 04/2008
1Synucleinopathies
01/2022
1Ataxia Telangiectasia (Louis Bar Syndrome)
12/2021
1Glioblastoma (Glioblastoma Multiforme)
12/2021
1Brain Neoplasms (Brain Tumor)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Mood Disorders (Mood Disorder)
05/2015
1Anxiety Disorders (Anxiety Disorder)
11/2013
1Mania (Manias)
11/2013
1Schizophrenia (Dementia Praecox)
11/2013
1Major Depressive Disorder (Major Depressive Disorders)
11/2013
1Dementia (Dementias)
06/2013
1Prodromal Symptoms
04/2013
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2008
1Sclerosis
01/2008
1Multiple Sclerosis
01/2008
1Restless Legs Syndrome (Restless Legs)
08/2006
1Stroke (Strokes)
11/2002

Drug/Important Bio-Agent (IBA)

5vinpocetineIBA
06/2011 - 08/2002
4Amyloid (Amyloid Fibrils)IBA
06/2013 - 11/2009
3Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2021 - 01/2018
3Biomarkers (Surrogate Marker)IBA
01/2018 - 04/2008
2Dopamine (Intropin)FDA LinkGeneric
01/2021 - 08/2006
2Pharmaceutical PreparationsIBA
01/2020 - 09/2015
2Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2015
2Amyloid beta-PeptidesIBA
09/2015 - 10/2010
22- (6- (methylamino)pyridin- 3- yl)- 1,3- benzothiazol- 6- olIBA
04/2013 - 11/2009
2Neuroprotective AgentsIBA
11/2003 - 08/2002
15-HT1A Serotonin ReceptorIBA
01/2022
1Protein Kinases (Protein Kinase)IBA
12/2021
1AZD1390IBA
12/2021
1ErbB Receptors (EGF Receptor)IBA
01/2020
1fenobamIBA
01/2020
1AZD9272IBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1LigandsIBA
01/2020
1Monoamine Oxidase (MAO)IBA
01/2020
1Metabotropic Glutamate 5 ReceptorIBA
01/2020
1osimertinibIBA
01/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2015
1Peroxidase (Myeloperoxidase)IBA
09/2015
1AZD3241IBA
09/2015
1Serotonin (5 Hydroxytryptamine)IBA
05/2015
1Antipsychotic Agents (Antipsychotics)IBA
11/2013
1Quetiapine Fumarate (Seroquel)FDA Link
11/2013
12- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
06/2013
1AZD2995IBA
04/2013
1PK 11195 (PK11195)IBA
01/2008
1(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA
01/2008

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2022
1Radiotherapy
12/2021
1Aftercare (After-Treatment)
09/2015
1Therapeutics
04/2013
1Oral Administration
08/2002